Current Relationships

We currently have several strategic alliances and other material agreements with various companies and institutions, including:

U.S. Department of Defense

AVI BioPharma has several contracts with the U.S. Department of Defense and its agencies funding its programs, including the Company’s clinical stage programs for the Ebola, Marburg, and Junín and Swine Flu viruses.

Eleos

AVI BioPharma entered into a license agreement with Eleos Inc. for the development of antisense drugs targeting p53 in human cancers, a well-studied human protein that controls cellular response to genetic damage.

AVI BioPharma has other strategic agreements with other companies that are currently not active. Please see our SEC filings for more information.

This page was last updated on July 31, 2010.